Your search relates to more than one category
Stockpreacher Penny Stock Blog (Free subscription) | 17 hours ago
Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS)(D*) * Financial status indicator is deficient: Issuer failed to meet NASDAQ continued listing requirements. Sunesis Pharmaceuticals Inc. (SNSS) is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. As of December 31,...
Market Wire (Free subscription) | 12/07/2009
SOUTH SAN FRANCISCO, CA (MARKET WIRE) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced positive data from two Phase 2 clinical trials of the Company's lead drug candidate, voreloxin. The results highlight voreloxin's strong efficacy and safety profile when used as a single agent or in combination with chemotherapy in patients with difficult to treat acute myeloid leukemia...
Stock Market Analysis (Free subscription) | yesterday
... Company Announces Signing of Definitive Merger Agreement With Adamis Pharmaceuticals Sunesis Pharmaceuticals Inc. (SNSS) - Sunesis Presents Positive Phase 2 Clinical Data of Voreloxin in Acute Myeloid Leukemia at the American Society of Hematology 2009 Annual Meeting InfoLogix, Inc. (IFLG) - No News EF Johnson Technologies, Inc. (EFJI) - No News EntreMed Inc....
Stock Market Analysis (Free subscription) | 12/04/2009
Today, 12/4/09, there are a few penny stock gainers breaking out to the upside. Be sure to check out the Top 2009 Penny Stock Gainers on the NYSE, Nasdaq, and AMEX. We also list OTC and Pink Sheets stock gainers below. You can find ALL Penny Stock Reports Here Penny Stock Gainers - December 4, 2009 Pacific Ethanol, Inc. (PEIX) - No News, oversold bounce EMCORE Corporation (EMKR) - Form 8-K for...
Forex Analytics (Free subscription) | 12/02/2009
At the 51st Annual American Society of Hematology Meeting in New Orleans, Sunesis Pharmaceuticals, Inc. (SNSS), an emerging biopharmaceutical company, is scheduled to present new clinical data of its anticancer drug candidate Voreloxin on Dec 5 and Dec.7. More: continued here (c)Autor: Forex Analytics Blog: earn money with Forex convert this post to pdf.Post from: [...] Post from: (c)Autor:...
